Adventage of Mesenchymal Stem Cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells

Folia Histochemica et Cytobiologica

Volumn 46, Issue 3, 2008, Pages 307-314

  Jarocha, Danuta ^a   Lukasiewicz, Ewa ^a,b   Majka, Marcin ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

CD105+; CD271+; Expansion; Isolation; MSC

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADAPALENE; AGGRECAN; ENDOGLIN; HERMES ANTIGEN; LEPTIN; NERVE CELL ADHESION MOLECULE; OSTEOCALCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSCRIPTION FACTOR RUNX2; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MESSENGER RNA; NAPHTHALENE DERIVATIVE; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CD105 SELECTION; CD271 SELECTION; CELL DIFFERENTIATION; CELL EXPANSION; CELL FREE SYSTEM; CELL ISOLATION; CELL LEVEL; CELL POPULATION; CELL SELECTION; CLONOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; BONE MARROW; BONE MARROW CELL; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY;

ANTIGENS, CD; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; NAPHTHALENES; OSTEOCALCIN; OSTEOGENESIS; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 58949104353     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0046-z     Document Type: Article

References (43)

1. Keating A. Mesenchymal stromal cells. Curr Opin Hematol. 2006;13:419-425.
2. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
3. Goshima J, Goldberg VM, Caplan AI. The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop. 1991;269: 274-283
4. Fibbe W. Mesenchymal stem cells. A potential source for skeletal repair. Ann Rheum Dis. 2002;61(Suppl II):ii29-ii31.
5. Smits AM, van Vliet P, Hassink RJ, Goumans MJ, Doevendans PA. The role of stem cells in cardiac regeneration. J Cell Mol Med. 2005;9:25-36.
6. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-313.
7. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol. 2006;44:215-230.
8. Friedenstein A.J, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267-274.
9. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood. 2007;109:1743-1751.
10. + stem cells identified in adult bone marrow. Leukemia. 2006;20:857-869.
11. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 2002;30:896-904.
12. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci. 2004;117:2971-2981.
13. Conget PA, Minguell JJ (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 1999;181:67-73.
14. Haynesworth SE, Baber MA, Caplan A. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 1992;13:69-80.
15. Gronthos S, Simmons P. The Growth Factor Requirements of STRO-1 - Positive Human Bone Marrow Stromal Precursors Under Serum-Deprived Conditions in vitro. Blood. 1995;85: 929-940.
16. Thomson TM, Rettig WJ, Chesa PG, Green SH, Mena AC, Old LJ. Expression of human nerve growth factor receptor on cells derived from all three germ layers. Exp Cell Res. 1998; 174:533-539.
17. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615-2625.
18. Tondreau T, Lagneaux L, Dejeneffe M et al. Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy. 2004;6:372-379.
19. Lagar'kova MA, Lyakisheva AV, Filonenko ES, et al. Characteristics of human bone marrow mesenchymal stem cells isolated by immunomagnetic selection. Bull Exp Biol Med. 2006;141:112-116.
20. Majumdar MK, Banks V, Peluso DP, Morris EA. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Phys. 2000;185:98-106.
21. + mesenchymal stem cells. Eur J Heart Fail. 2006;8:555-563.
22. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Lambertenghi deliliers G. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol. 2002;30:783-791.
23. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991;78:55-62.
24. Simmons PJ, Torok-Storb B. CD34 Expression by Stromal Precursors in Normal Human Adult Bone Marrow. Blood. 1991;11:2848-2853.
25. Gronthos S, Zannettino AC, Hay SJ et al. Molecular and cellular characterization of highly purified stromal stem cells derived from human bone marrow. J Cell Science. 2003;116:1827-1835.
26. Jones EA, Kinsey SE, English A et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002;46:3349-3360.
27. Boiret N, Rapatel C, Veyrat-Masson R et al. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol. 2005;33:219-225.
28. Friedenstein AJ, Gorskaja U, Kalugina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267-274.
29. Angelopoulou M, Novelli E, Grove JE et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol. 2003;31:413-420.
30. Vidal MA, Kilroy GE, Johnson JR, Lopez MJ, Moore RM, Gimble JM. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg. 2006;35:601-610.
31. + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica. 2005;90:516-525.
32. Tolar J, Nauta AJ, Osborn MJ et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 2007;25:371-379.
33. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 2003;121:368-374.
34. + cells. Stem Cells. 2006;24:1728-1737.
35. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462-471.
36. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA. 2000;28:3213-3218.
37. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-754.
38. Nakashima K, Zhou X, Kunkel G et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108: 17-29.
39. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994;79:1147-1156.
40. Yin T, Li L. The stem cell niches in bone. J Clin Invest. 2006;116:1195-1201.
41. Corazza F, Hermans C, Ferster A, Fondu P, Demulder A, Sariban E. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children. Pediatr Res. 2004;55:152-158.
42. Li J, Law HK, Lau YL, Chan GC. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol. 2004;127:326-334.
43. + cells. Bone Marrow Transplant. 1998;22:457-468.